LeonaBio, Inc.
LONA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001620463
No open-market purchases or sales by LeonaBio, Inc. insiders were filed in the last 90 days; 44 institutions reported holding it in 13F filings for Q2 2026, worth $66.8M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in LeonaBio, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 98
- 0 vs. Q2 2022
- Shares held
- 22.2M
- +98.7K (+0.4%) vs. Q2 2022
- Total value
- $66.5M
- −$1.46M (−2.2%) vs. Q2 2022
- New holders
- 20
- 34 more added
- Sold out
- 20
- 17 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LONA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 44 | $66.8M |
| Q1 2026 | 40 | $66.0M |
| Q4 2025 | 42 | $46.7M |
| Q3 2025 | 34 | $7.07M |
| Q2 2025 | 51 | $5.30M |
| Q1 2025 | 54 | $5.00M |
| Q4 2024 | 56 | $10.5M |
| Q3 2024 | 58 | $7.19M |
| Q2 2024 | 65 | $58.8M |
| Q1 2024 | 75 | $59.5M |
| Q4 2023 | 65 | $53.2M |
| Q3 2023 | 70 | $43.3M |
| Q2 2023 | 77 | $64.6M |
| Q1 2023 | 83 | $59.5M |
| Q4 2022 | 94 | $73.9M |
| Q3 2022 | 98 | $66.5M |
| Q2 2022 | 98 | $68.0M |
| Q1 2022 | 106 | $353.7M |
| Q4 2021 | 106 | $341.8M |
| Q3 2021 | 93 | $234.0M |
| Q2 2021 | 89 | $253.3M |
| Q1 2021 | 69 | $484.4M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding LeonaBio, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Group One Trading, L.P. | 0 | $0 | 0.00% | −153,115−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −115,900−100.0% | Sold out |
| AWH Capital, L.P. | 0 | $0 | 0.00% | −115,000−100.0% | Sold out |
| P Schoenfeld Asset Management LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −95,192−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −55,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −33,900−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −31,972−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −20,990−100.0% | Sold out |
| Telemetry Investments, L.L.C. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −14,903−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −12,017−100.0% | Sold out |
| DLD Asset Management, LP | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −2,941−100.0% | Sold out |
| Eagle Bay Advisors LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Castleview Partners, LLC | 0 | $0 | 0.00% | −107−100.0% | Sold out |
| Blue Bell Private Wealth Management, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −137−100.0% | Sold out |